Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (3299)	6/6/1998 11:49:00 AM
From: BigKNY3	Respond to of 9523

Here's a surprise: a favorable article in this week's Barrons. Thanks again Anthony! BigKNY3 Brooke says that one of the best-performing stocks, Pfizer, may have upside potential even at its recent price of $104, or 38 times '99 earnings estimates of $2.70 a share. Pfizer continues to see strong sales growth for its billion-dollar antidepressant, Zoloft, and its antibiotic Trovan recently got the FDA's blessing for use against a broad spectrum of germs. Viagra can't be ignored, either. Today's stock price suggests that investors see annual sales of Viagra topping out at between $2.5 and $3 billion a few years from now, but Brooke thinks the pill's opportunity is greater still. www3.techstocks.com

To: James Baker who wrote (3299)	6/6/1998 1:00:00 PM
From: Tunica Albuginea	Respond to of 9523

James Baker, I don't disagree with a lot you are saying. However may I suggest you buy the last issue of Barons and read the article " Deserting the Bulls by K Welling, "AN interview with J Toms, a long standing bull turned bear ". This is the best forward looking article on the market I've seen all year this is the best forward looking article on the market that I've seen in a very very long time. Even though I don't disagree with many things in your investment style, consider reading this article and putting your investment stocks in its context.The tables alone are worth the price IMHO since a picture is worth a thousand words. Put all stocks including Healthcare in this article's context. I hope you find it as insightful as did. Unfortunately may computer does not let me access it; here is the URL interactive.wsj.com TA